Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating rising doses of BI 187004 in adults with Type 2 diabetes, focusing on safety, tolerability, and pharmacokinetics/pharmacodynamics; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 187004

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED